Juvenile myoclonic epilepsy and human leukocyte antigens  by Moen, Torolf et al.
Seizure 1995; 4:119-122 
Juvenile myoclonic epilepsy and human leukocyte 
antigens 
TOROLF MOEN, EYLERT BRODTKORB*, RALF PETER MICHLER* & ASTRID HOLST 
Department of Immunology and Blood Bank, *Department of Neurology, Trondheim University Hospital, 
Trondheim, Norway 
Correspondence: Professor T. Moen, Department of Immunology and Blood Bank, Trondheim University Hospital, 
N-7006 Trondheim, Norway. 
The idiopathic generalized epilepsies (IGE) occur with a high aggregation within families. Juvenile myoclonic 
epilepsy (JME) is recognized as a commonly occurring form of idiopathic generalized epilepsy. A possible 
association between JME and HLA antigens was investigated by serological typing of human leukocyte antigens 
(HLA) class I antigens and by DNA oligotyping of class II antigens. Twenty-four patients and 129 controls, all 
Caucasians of Scandinavian descent, were tested. Uncorrected there was a significant positive association (Relative 
risk (RR) = 8.07) to B17 and a significant negative association (RR = 0.13) to B8 as well as DRBI*3. The negative 
association to DQ alleles DQAI*0501 and DQBI*0201, which are in strong linkage disequilibrium with the alleles 
B8 and DRBI*3, was weaker and not significant, thus giving no clue as to a primary HLA-DQ association of JME. 
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INTRODUCTION 
The epilepsies are divided into two major classes: 
the generalized and the localization-related pi- 
lepsy syndromes. Both are separated into 
idiopathic (no other underlying cause than a 
presumed genetic predisposition), symptomatic 
(known aetiology), and cryptogenic (unknown 
aetiology, but presumably symptomatic) ~. 
Juvenile myoclonic epilepsy (JME) is a com- 
mon idiopathic generalized epilepsy syndrome, 
which, clinically, is easily identified. It occurs in 
5-10% of patients with epilepsy. The characteris- 
tic myoclonic jerks predominantly occur after 
premature awakening. Most patients have gene- 
ralized tonic-clonic seizures (GTCs), and up to 
one third have typical absence seizures 2.
Many investigations have been performed in 
search of an HLA association in epilepsy. Some 
patient series have been mixtures of different 
syndromes, and the results may seem confusing. 
Previously, mainly HLA class I antigen associa- 
tions were studied as reviewed by Eeg-Olofsson et 
al 3. Lately, the interest has focused on JME. 
Possible associations to HLA class I antigens 4 as 
well as class II (DR) 5 have been reported. 
The first linkage study was reported by 
Delgado-Esqueta et al 4 in JME and concluded 
with a lod score over 3.0 for a localization of the 
disease gene to the HLA region (chromosome 
6p21.3) and dominant inheritance with a penet- 
rance of 0.9 as the most probable mode of 
inheritance. JME and its associated EEG trait 
had been ascribed a genetic predisposition, and 
the HLA region on the short arm of chromosome 
6 thus became involved as the tentative location 
of a disease gene. The linkage studies of 
Delgado-Esqueta et al have since mainly been 
confirmed by two studies 6"7. Recent investigations 
have, however, provided evidence against linkage 
between JME and the HLA region in some 
pedigrees s''J'"~ suggesting heterogeneity within the 
syndrome of JME. 
The aim of the present study was to re-evaluate 
a possible HLA association of JME, especially 
regarding the class II antigens, as DNA oligotyp- 
ing now gives a much better discrimination 
between alleles than the former serotyping, and 
because this class of antigens, especially the DQ 
series, have been drawn into focus of interest as 
the most probable predisposing HLA genes in an 
increasing number of diseases ~. 
1059-1311/95/020119 + 04 $08.00/0 O 1995 British Epilepsy Association 
120 T. Moen et aL 
SUBJECTS AND METHODS 
Twenty-four consecutive outpatients with JME 
were examined. They were 13 females and 11 
males with an age range from 13 to 64 years 
(mean, 28 years). Epilepsy onset age ranged from 
8 to 19 years (mean, 15 years). All patients had 
experienced myoclonic jerks with morning pre- 
dominance: 22 had suffered from GTCs, and five 
presented a history of absence seizures, three 
with atonic components. 
Table 1: Distribution of HLA alleles among juvenile 
rnyoctonic epi lepsy patients and controls 
HLA alleles JME Controls Pf RR 
patients n = 129 
n = 24 no. (%) 
no. (%) 
DQAI*0101 5 (20.8) 31 (24.0) ns 0.83 
DQAl*0102 I1 (45.8) 55 (42.6) ns 1.14 
DQAI*0103 4 (16.7) 22 (17.1) ns 0.97 
DQAI*0201 6 (25.0) 22 (17.1) ns 1.62 
DQAI*030X§ 10 (41.7) 55 (42.6) ns 0.96 
DQAI*0401 3 (12.5) 11 (8.5) ns 1.53 
DQAI*050111 3 (12.5) 37 (28.7) ns 0.36 
DQAI*0601 0 (0.0) 1 (0.8) ns 1.75 
DQBl*0501 4 (16.7) 28 (21.7) ns 0.72 
DQBl*0502 0 (0.0) I (0.8) ns 1.75 
DQBI*05031 2 (8.3) 3 (2.3) ns 3.82 
DQBl*05032 0 (0.0) 0 (0.0) - -  - -  
DQBI*0601 0 (0.0) 0 (0.0) - -  - -  
DQBI*0602 6 (25.0) 36 (27.9) ns 0.86 
DQBI*0603 4 (16.7) 23 (17.8) ns 0.92 
DQBl*0604,5 4 (16.7) 24 (18.6) ns 0.88 
DQBI*0201 4 (16.7) 47 (36.4) ns 0.35 
DQBI*0301 6 (25.0) 23 (17.8) ns 1.54 
DQBI*0302 8 (33.3) 34 (26.4) ns 1.40 
DQBI*0303X 2 (8.3) 14 (10.9) ns 0.75 
DQBI*0401 0 (0.0) 0 (0.0) - -  - -  
DQBl*0402 3 (12.5) 13 (10.1) ns 1.27 
DRBI* I~ 4 (16.7) 24 (18.6) ns 0.88 
DRBI*2 8 (33.3) 37 (28.7) ns 1.24 
DRBI*3 1 (4,2) 33 (25.6) 0.04 0.13 
DRBI*4 10 (41.7) 46 (35.7) ns 1.29 
DRBI*5 2 (8.3) 7 (5.4) ns 1.13 
DRBI*6 10 (41.7) 50 (38.8) ns 1.13 
DRBI*7 6 (25.0) 22 (17.1) ns 1.72 
DRBI*8 3 (12.5) 14 (10.9) ns 1.17 
DRBI*9 0 (0.0) 9 (7.0) ns 0.26 
DRBI*10 1 (4.2) 4 (3.1) ns 1.36 
n = 124 
A1 6 (25.0) 33 (26.6) ns 0.92 
B8 1 (4.2) 32 (25.8) 0.04 0.13 
B17 4 (16.7) 3 (2.4) 0.01 8.07 
t P-values are not corrected. 
:]:The broad DRBI specificities are denoted DRBI* I  to 
DRBI*10. 
§ X denotes all sub-alleles described. 
II Three sub-alleles of DQAI*0501 are described recently jz. 
For convenience the denotion DQAI*0501 is used for these 
sub-alleles. 
The control group consisted of 129 persons, 
randomly selected members of the hospital staff 
and blood donors. Patients and controls were all 
Caucasians of Scandinavian descent and all living 
in the same geographical rea of Mid-Norway. 
INVESTIGATIONS 
The PCR amplification and SSO probing of HLA 
DR and DQ were performed as previously 
described t~. The nomenclature for the HLA 
alleles and the specificities of the SSO probes are 
in accordance with a recently-published gene 
registry of HLA class II nucleotide sequences j3,
excepting the broad specificities of DRB1. These 
are denoted as follows: DRBI*01,DRBI*15,16, 
DRBI*03, DRBI*04, DRBI*l l ,12, DRBI*13,14 
DRBI*07,DRBI*08, DRBI*09 and DRBI*10. 
These DRB1 designations correspond to the 
more widely known serological DR 
nomenclature. 
Serological HLA typing was performed as 
described by Vartdal and co-workers j4. 
The chi-square test with Yates' correction was 
used to compare the number of patients and 
controls positive for an allele or a haplotype. The 
level of significance was set to 0.05. Relative risk 
(RR) was calculated by Woolf's formula, with 
Haldane's modification in sets containing zero 15. 
RESULTS 
The results of the HLA typings are shown in 
Table 1. The frequencies of all the DNA-typed 
class II alleles are presented. The distribution of 
class II antigens among controls are quite similar 
to what has been published for another Norwe- 
gian population ~6. Only the class I antigens 
significantly deviating from the controls or of 
special interest are included. The P values 
presented have not been corrected for number of 
antigens tested. 
We found a statistically significant positive 
association between JME and the HLA antigen 
B17 and a significant negative association bet- 
ween JME and the antigens B8 and DRBI*3. We 
found no clue for a stronger association to the 
DQ series of class II alleles than to class I or to 
DRB1 alleles. 
DISCUSSION 
A great number of HLA associated iseases have 
been reported throughout the last decades, most 
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of which have a dysregulated immune system and 
autoimmunity as predominant features. (For 
review see Tiwari and Terasaki~7.) Such associa- 
tions are now generally supposed to be primarily 
to alleles of the HLA molecules proper and to 
depend on the different peptide binding pro- 
perties which these alleles have when presenting 
autoantigens and exogenous antigens to the 
immune-regulating T-lymphocytes ~8. Other dis- 
eases are HLA associated merely because the 
predisposing ene happens to be located in the 
HLA region without any overt involvement of the 
immune system. The results of this kind of 
investigation are, for some diseases, much depen- 
dent on the ethnic background and homogeneity 
of the population studied. 
The results of clinical family studies have 
shown that the different forms of idiopathic, 
generalized epilepsies may share a common 
genetic factor 4. In addition, there is a tendency 
towards a familial aggregation of the more 
specific syndromes, uch as childhood and juve- 
nile absence pilepsies, JME, and epilepsy with 
GTCs on awakening. Some degree of overlap 
between the forms during the clinical course 
seems to occur, and it has been suggested that a 
defect on chromosome 6p predisposes to the 
idiopathic generalized epilepsies in general jg. 
An association between epilepsy in children 
and HLA-B17 has been reported by Serclova et 
al 2°. Their patients eemed to suffer from various 
seizure types, predominantly belonging to the 
localization-related form of epilepsy. None of the 
children seemed to have JME. The relevance of 
the B17 association that we detected in JME thus 
needs to be confirmed. 
The HLA antigens A1; B8, DR3 (DRBI*3) 
together with the DQ alleles DQAI*0501 and 
DQBI*0201 are in strong linkage disequilibrium 
(occur together on the same chromosome more 
often than expected) and represent he most 
frequent extended HLA haplotype in the 
Caucasian and especially northern European 
population ~6'2~'22. Our finding of a negative 
association between JME and the HLA hap- 
lotype carrying B8, DRBI*3 has not been 
reported previously. Eeg-Olofsson et a123 have, 
however, reported anegative association between 
HLA-A1, B8 and a study mainly consisting of 
children with benign epilepsy of childhood and 
absences. They did not determine the class II 
antigens. In our study the negative association 
does not include A1, whereas it does include 
DRBI*3 and the DQ-alleles DQAI*0501 and 
DQBI*0201. The negative DQ associations are 
not statistically significant, however. The negative 
association that we detected for HLA-B8, 
DRBI*3 in JME contrasts to the positive 
association reported for HLA-A1, B8 by Fichsel 
and Kessler 24 as well as by Rivas 25 in absence 
epilepsy. For HLA-B8 our result gives a chi- 
square of 10.5 versus the result of Fichsel and 
Kessler which may accentuate he probability that 
JME and absence pilepsy are indeed genetically 
different. 
The possible HLA associations previously 
reported in JME: B18 (negative), B52, B625, and 
DRw64 were not detected in our series, i.e. we 
were typing for B5 and B15 which are including 
B52 and B62, respectively. 
Also in the localization-related epilepsies some 
degree of heredity may be present 26"27. We have 
HLA-typed a study of 20 patients uffering from 
localization-related epilepsy with complex partial 
seizures, no cerebral MR abnormalities, and with 
cryptogenic ause, without detecting any HLA 
association (unpublished). 
The total picture of a possible genetic relation- 
ship between epilepsy and the HLA region is 
rather bewildering, and it is difficult to reach a 
decisive conclusion that such a relationship exists 
at all. If epilepsy syndromes are HLA-associated, 
the different HLA associations reported probably 
favour the idea of an association that is primarily 
not to the class I or II antigens, and the disease is 
also not of an overt autoimmune character, even 
if a dysregulation of T-lymphocytes in JME 
patients has been described TM. HLA associations 
of typical autoimmune diseases mainly tend to 
extend across ethnic and even racial borders. Of 
the HLA associated diseases of the central 
nervous system, multiple sclerosis has a clearly 
autoimmune pathogenesis that is mainly geneti- 
cally determined 2~, whereas in narcolepsy, the 
disease xhibiting the strongest HLA association 
detected so far, autoimmunity is not an evident 
characteristic 3°. 
Of 58 HLA alleles studied in JME we detected 
the same positive association as Serclova et al 2° 
and partly the same negative association as 
Eeg-Olofsson et a123 did in other epileptic 
syndromes. The question of whether this is 
incidental or indicates a common genetic aetiolo- 
gic factor, needs further investigation. Genetic 
linkage studies can be performed on whichever 
family with two or more occurrences of a disease 
irrespective of ethnic background, and will also 
give information on a possible genetic relation- 
ship between for instance different IGE syn- 
dromes. It should be stressed, however, that 
HLA association studies must be performed on 
clinically as well as ethnically homogenous 
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patient series. If these issues are going to be 
settled, it is important that investigations per- 
formed are comparable if not sufficiently com- 
prehensive to be conclusive alone. 
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